Stay updated with breaking news from Nasdaq Lnth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lantheus (NASDAQ:LNTH – Get Free Report) issued an update on its FY24 earnings guidance on Thursday morning. The company provided earnings per share guidance of $7.00-7.20 for the period, compared to the consensus earnings per share estimate of $6.58. The company issued revenue guidance of $1.50-1.52 billion, compared to the consensus revenue estimate of $1.43 […]
Lantheus (NASDAQ:LNTH – Get Free Report) issued an update on its second quarter earnings guidance on Thursday morning. The company provided earnings per share guidance of $1.81-1.86 for the period, compared to the consensus earnings per share estimate of $1.66. The company issued revenue guidance of $380-390 million, compared to the consensus revenue estimate of […]
Lantheus (NASDAQ:LNTH – Get Free Report) updated its FY24 earnings guidance on Thursday. The company provided earnings per share guidance of $7.00-7.20 for the period, compared to the consensus earnings per share estimate of $6.58. The company issued revenue guidance of $1.50-1.52 billion, compared to the consensus revenue estimate of $1.43 billion. Lantheus also updated […]
Lantheus (NASDAQ:LNTH – Get Free Report) will post its quarterly earnings results before the market opens on Thursday, May 2nd. Analysts expect Lantheus to post earnings of $1.34 per share for the quarter. Individual that wish to listen to the company’s earnings conference call can do so using this link. Lantheus (NASDAQ:LNTH – Get Free […]
Lantheus (NASDAQ:LNTH – Get Free Report) and Virax Biolabs Group (NASDAQ:VRAX – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, profitability, dividends, risk, valuation, earnings and institutional ownership. Risk and Volatility Lantheus has a beta of […]